CarTarDis cardiovascular target validation results published in Circulation
November 28, 2017
We are proud to announce that the results of the validation of the selected CarTarDis targets have been and will be disseminated in scientific manuscripts and posters. The abstracts of the most recent posters, presented at the American Heart Association conference in Anaheim, CA in November 2017, have been published in Circulation, November 14, 2017, Volume […]
CarTarDis cardiovascular target validation workflow poster at EATRIS
November 28, 2017
Directed by the experienced pharmaceutical scientists in our team and advised by experienced drug developers and entrepreneurs in our External Advisory Board, CarTarDis designed a rational approach to accurately reflect the pharmaceutical process, adopting best practices from pharmaceutical industry from its start. First, available and emerging molecular data from three large independent cardiovascular cohorts was […]
CarTarDis consortium official end date
November 28, 2017
The EC FP7 funded project CarTarDis (Cardiovascular Target Discovery) aimed to apply the high quality expertise and resources within its multi-partner consortium to discover novel therapeutic drug targets with a high level of clinical correlation to cardiovascular disease (CVD). The project adopted a strong pharmaceutical work flow in which the 13 consortium partners formed a […]
CarTarDis dissemination activities fall 2017
August 21, 2017
Our CarTarDis collaborative project is near it’s end. With only a few weeks to go, and many exciting results of our activities becoming available in these weeks, we have a number of dissemination activities planned. We submitted several abstracts and are pleased to announce that CarTarDis will be represented by five poster presentations at two […]
Heart@Target, joint meeting of three FP7 consortia on Cardiovascular research.
October 2, 2016
Three consortia of EU FP7 projects which are focused on identification and validation of new targets for drugs in cardiovascular disease organized a joint meeting in Zandvoort, The Netherlands on Tuesday the 27th and Wednesday 28th of September 2016. With 60 participants from the three consortia, represented by researchers from academia, several SME’s and big […]
Cartardis partner Imabiotech presented poster ‘Multimodal Analysis and Mass Spectrometry Imaging of Atherosclerotic Plaque Tissue’ at the 2016 ASMS meeting
August 24, 2016
Poster CarTarDis Imabiotech ASMS 2016 Within the CartarDis project we evaluate several CVD targets and their mechanism of involvement in the development of CVD is studied with multimodal molecular imaging techniques. Preliminary data obtained within the CarTarDis project showed that mechanisms related to lipid metabolism and inflammation are genetically and functionally linked to cardiovascular disease […]
A systematic evaluation of the cellular innate immune response during the process of human atherosclerosis, paper supported by CarTarDis published by AHA
August 16, 2016
The concept of innate immunity is well recognized within the spectrum of atherosclerosis, which is primarily dictated by macrophages. Although current insights to this process are largely based on murine models, there are fundamental differences in the atherosclerotic microenvironment and associated inflammatory response relative to humans. In this light, Cartardis partner, LUMC characterized the cellular […]
Paper on cardiac hypertrophy published by Umeå University
June 3, 2016
Cardiac hypertrophy and decreased high-density lipoprotein cholesterol in Lrig3-deficient mice. This interesting paper was financially supported by CarTarDis and published by partner Umeå University in Am J Physiol Regul Integr Comp Physiol (March 23, 2016). Genetic factors confer risk for cardiovascular disease. Recently, large genome-wide population studies have shown associations between genomic loci close to LRIG3 […]
PolyGene presented poster ‘Novel Glucocorticoid-based Gene Regulation System’ at Transgenic Technology Meeting
April 6, 2016
Polygene presented a poster entitled ‘Novel Glucocorticoïd-based Gene Regulation System’ the 13th Transgenic Technology Meeting in Prague, held March 20-23 2016 and organized by the International Society of Transgenic Technologies (ISTT) (http://www.transtechsociety.org/tt2016/). Over 600 scientists from all over the world attended this much sought-after meeting, and PolyGene was participating with four representatives. The program was dense with full […]
New publication supported by CarTarDis published by Diabetes care
September 28, 2015
A peer rewiewed publication entitled ‘Effects of metformin on metabolite profiles and LDL cholesterol in patients with Type 2 Diabetes’ was published by the journal Diabetes Care few weeks ago. This publication was financially supported by CarTarDis. CarTarDis partner HMGU, CarTarDis team members Stefan Brandmeier, Rui-Wang Sattler and Thomas Meitinger significantly contributed to this exciting paper. The publication of […]